Necessity for Animal Research

Numbers & Types of Animals Used

Tests Without Animals

Animals in Society

Government Regulations

School Speakers Program

Other Sources of Information

Frequently Asked Questions

Contact BRET

Index

Home

The role of mice in developing an anti-Alzheimer vaccine

Dementia is caused by different illnesses that affect the brain and is characterised by;
  • Loss of memory
  • Mood changes
  • Difficulty in understanding people and finding the right words when speaking

The most common form of dementia is Alzheimer's, a disease that destroys brain cells and affects thinking and memory.

It is estimated that dementia affects about 750,000 people in the UK and about 7.4 million world-wide. There is as yet no effective cure or treatment for Alzheimer's disease.

Scientists believe that the nerve cells in the brain are destroyed by the formation of plaques or plates of protein material, (beta-amyloid protein), building up in the brain.

Scientists at Elan Pharmaceuticals Inc., a company based in San Francisco, have genetically engineered a mouse which develops the characteristics of Alzheimer's disease.

The scientists then developed a vaccine that would induce the mice's own immune system to recognise the protein plaques as foreign and so destroy them. The majority of vaccinated mice showed no plaque formation. Others did develop plaques but much less than in unvaccinated animals. The vaccinated mice showed no deterioration in their nerve cells.

Following these studies in mice, studies have now started in humans to see if this technique can be safely used to combat this distressing and widespread disease.


Move Back to News -
to choose a new subject
Move back to News

  Home | Index | Contact Us | FAQ | Links
Necessity for Animal Research | Numbers and Types of Animals | Tests Without Animals | Animals in Society | Gov. Regulations | School Speaker Program | Research animals in the news | Care and welfare of research animals
© 2007 BRET